The French study included 30,202 patients. Zachary Stieber, 11/3/2023 Epoch Health People who received hydroxychloroquine were less likely to die than those who did not, according to a new study. Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared to 4.8 percent of patients who did […]
BMJ 2023; 382 doi: https://doi.org/10.1136/bmj-2022-073923 (Published 18 August 2023)Cite this as: BMJ 2023;382:e073923, Rachel L Brown123, Laura Benjamin24, Michael P Lunn12, Tehmina Bharucha25, Michael S Zandi12, Chandrashekar Hoskote6, Patricia McNamara2, Hadi Manji1 Abstract Although neurological complications of SARS-CoV-2 infection are relatively rare, their potential long term morbidity and mortality have a significant impact, given the large numbers of infected patients. Covid-19 is […]
BMJ 2023; 383 doi: https://doi.org/10.1136/bmj-2023-076810 (Published 09 October 2023)Cite this as: BMJ 2023;383:e076810Read the full collection: Food for Thought 2023 Carmen Piernas, senior research fellow, Jordi Merino, associate professor ,Correspondence to: C Piernas Carmen Piernas and Jordi Merino argue that suboptimal diet and poor metabolic health aggravated the covid-19 pandemic and require greater attention to increase population resilience and reduce health inequalities The covid-19 pandemic […]
Authors: Peng Pi1† Zhipeng Zeng1† Liqing Zeng1 Bing Han1 Xizhe Bai2 Shousheng Xu3*Front. Pharmacol., 03 August 2023, Sec. Respiratory Pharmacology, Volume 14 – 2023 | https://doi.org/10.3389/fphar.2023.1218059 As the outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in Hubei Province, China, at the end of 2019. It has brought great challenges and harms to global […]
BMJ 2023; 382 doi: https://doi.org/10.1136/bmj.p1983 (Published 20 September 2023)Cite this as: BMJ 2023;382:p1983Linked OpinionAs a doctor with long covid, I feel abandoned by the NH Adele Waters, freelance journalist Unable to work or to play with their children, forced to sell their homes or facing insolvency—doctors with long covid deserve more support from the government and the NHS, writes Adele Waters When Kelly […]
BMJ 2022; 378 doi: https://doi.org/10.1136/bmj-2022-072117 (Published 22 September 2022)Cite this as: BMJ 2022;378:e072117 Trisha Greenhalgh, Manoj Sivan, Brendan Delaney, Rachael Evans, Ruairidh Milne, What you need to know This article updates and extends a previous BMJ Practice Pointer published in August 2020 when almost no peer reviewed research or evidence based guidance on the condition was available.1 In this update we outline how clinicians might […]
OCT 28, 2023 – Authored by Marina Zhang, The Epoch Times Opinion Piece Please Read–Bifidobacteria explained. Research has shown that COVID-19 mRNA vaccines reduce bacteria belonging to the Bifidobacteria genus, a common and beneficial gut bacteria. COVID vaccination is also linked to reduced gut biodiversity. Works by gastroenterologist Dr. Sabine Hazan, the CEO of ProgenaBiome, a […]
Authors: Chien-Ting Wu , Peter V. Lidsky , Yinghong Xiao , Carlos Milla, Raul Andino, Peter K. Jackson December 01, 2022DOI:https://doi.org/10.1016/j.cell.2022.11.030 Highlights Summary How SARS-CoV-2 penetrates the airway barrier of mucus and periciliary mucins to infect nasal epithelium remains unclear. Using primary nasal epithelial organoid cultures, we found that the virus attaches to motile cilia via the ACE2 […]
The often debated treatment did not improve outcomes in critically ill patients Published 10/27/23, Hannah Murphy, The Messenger High doses of intravenous vitamin C are no more effective than a placebo when it comes to treating patients hospitalized with severe COVID-19 infections, a new study shows. Published in JAMA, the study compared treatment regimens and their resultant […]
By Angelo DePalma, Ph.D. The Defender According to an analysis, published this month in the International Journal of Vaccine Theory, Practice, and Research, of Pfizer-BioNTech COVID-19 vaccine clinical trial data, the vaccine makers hid fatality data from regulators in order to qualify for Emergency Use Authorization. Pfizer-BioNTech delayed reporting vaccine-associated deaths among BNT162b2 clinical trial participants […]